Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

2 Unstoppable Green Flags for AbbVie

TheMotleyFool

0 0

When it comes to AbbVie (NYSE: ABBV), investors have been worrying about one thing: an eventual drop in sales of its blockbuster Humira. The immunosuppressive drug is used for various diseases, including rheumatoid arthritis.

Last year, Humira generated more than $20 billion in sales. But as of next year, competition may start eating away at Humira's market share.

That may look like terrible news, but there's a big silver lining around this dark cloud. And the following two charts offer us the details.

Source Fool.com

Like: 0

ABBV

Teilen